Search results for:
No result found! Try with different keywords!
Users
Organizers
Events
Advertisement
Oh Snap, this is a past event! 😵

Do you want to get notified when this event happens again?

Depression in 2020: Biomarkers, Technologies and Novel Therapies

Advertisement

Depression in 2020: Biomarkers, Technologies and Novel Therapies


A one-day Continuing Medical Education conference for physicians, other health professionals, and trainees.


AGENDA

 

7:30am-8:00am                                   Breakfast & Registration

8:00am-8:15am                                   Welcome and Introductions

Sagar Parikh, MD, University of Michigan, Ann Arbor, Michigan

Opening Remarks

Sidney Kennedy, MD, FRCPC, St. Michael’s Hospital, Toronto, Ontario

Raymond Lam, MD, FRCPC, University of British Columbia, Vancouver, British Columbia

 

8:15am-9:00am                  Plenary 1: Biomarkers and Bitcoin: Transmogrifying hype into patient care

Roy Perlis, MD, MSc, Massachusetts General Hospital, Boston, Massachusetts

 

9:00am-9:45am                 Plenary 2: Imaging-based Biomarkers in Depression

Jonathan Downar, MD, PhD, FRCPC, University Health Network, Toronto, Ontario

 

9:45am-10:00am              Break

 

10:00am-11:30am           Symposium 1: Emerging Treatments in Depression

 

11:30am-12:30pm           Lunch

 

12:30pm-2:00pm              Symposium 2: Technology and Health

 

2:00pm-2:15pm                                   Break

 

2:15pm-3:45pm                                   Concurrent Workshops

 

3:45pm-4:00pm                                   Closing Remarks

Sagar Parikh, MD, University of Michigan, Ann Arbor, Michigan

 

SYMPOSIA

 

Symposium 1: Emerging Treatments in Depression

 

Ketamine Treatments (30 minutes)

Pierre Blier, MD, PhD, University of Ottawa, Ottawa, Ontario

 

Microbiome (30 minutes)

Jane Foster, PhD, McMaster University, Hamilton, Ontario

 

Theta Burst Stimulation for the Treatment of Depression (30 minutes)

Daniel Blumberger, MD, MSc, FRCPC, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario

 

Symposium 2: Technology and Health

 

m-Health and Depression (40 minutes)

John Torous, MD, MBI, Harvard Medical School, Boston, Massachusetts

 

Internet CBT Tools for Depression (25 minutes)

Lena Quilty, PhD, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario

 

EEG Devices for Mood and Anxiety (25 minutes)

Faranak Farzan, PhD, Simon Fraser University, Surrey, British Columbia

 

Concurrent Workshops  

Cannabis and Mood Disorders

Oyedeji Ayonrinde, FRCPsych, MBA, Queen’s University, Kingston, Ontario

 

CANMAT Bipolar Guidelines

Benicio Frey, MD, MSc, PhD, McMaster University, Hamilton, Ontario

Valerie Tourjman, MD, Université de Montréal, Montreal, Quebec

 

CANMAT Depression Guidelines

Sophie Grigoriadis, MD, PhD, FRCPC, University of Toronto, Toronto, Ontario

Sagar Parikh, MD, University of Michigan, Ann Arbor, Michigan

 

Note: Each attendee will be able to attend 1 of the 3 concurrent workshops.

 

FEES

 

Physicians                                   $275

 

Other Health Professionals         $175

 

Fellows & Other Trainees             $75

 

CONTINUING MEDICAL EDUCATION (CME) CREDITS

 

Credits for Specialists

Royal College of Physicians & Surgeons of Canada – number of credits pending

 

College of Family Physicians of Canada – number of credits pending

 

ACKNOWLEDGEMENT OF SUPPORT

 

We would like to acknowledge the following sponsors that have generously awarded this conference with an unrestricted educational grant. The grant has been awarded in accordance with the Canadian Medical Association (CMA) and Canada’s research-based pharmaceutical companies:

 

Gold

 

Allergan Inc. (Canada), Otsuka Canada Pharmaceutical Inc.

 

Silver

 

Sunovion Pharmaceuticals Canada Inc.

 

FAQs

 

What time do the doors open?

Doors and registration will open at 7:30am.

 

Will meals/refreshments be provided?

Breakfast and lunch will be provided. Tea and coffee refreshments will also be served.

 

How do I get to the event?

The Chelsea Hotel (33 Gerrard Street W., Toronto, Ontario) is located at a six-minute walk from Yonge-Dundas Square. The Chelsea Hotel has multiple entrances and can be accessed from Gerrard Street, Elm Street and Yonge Street. The conference will take place in the Mountbatten Salon on the second floor. Breakout rooms will be located on the same floor.

 

Public Transit

If travelling by public transit, the closest TTC stations are either Dundas or College Station.

 

Driving & Parking

For those driving, entrance underground parking is located on the south side of Gerrard Street in front of the lobby entrance. Pricing can be found here: http://www.chelseatoronto.com/en/hotel/chelsea-services.


Accessibility

The Chelsea hotel is accessible from street level. Wheel Trans pick up and drop-off is located on the south side of Gerrard Street in front of the lobby entrance. More information can be found here: http://www.chelseatoronto.com/en/accessibility/.


Refund Policy

In case you are unable to attend the conference, refunds will be available up until January 3rd, 2019 (30 days before the event). Please note a processing fee of $50 CAD will be retained. 

If for any reason the conference is cancelled, registrants will be advised and full refunds will be issued.

 

QUESTIONS?

 

Please contact Anum at c2hpdmppYXJ3YW5hIHwgc21oICEgY2E= with the message subject: Depression in 2020 Conference.

 

PLANNING COMMITTEE

 

CHAIR

Claudio Soares, MD, PHD, FRCPC, MBA

Professor & Head, Department of Psychiatry, Queen’s University School of Medicine (Kingston, Ontario)

 

Jane Foster, PhD

Associate Professor, Department of Psychiatry & Behavioural Neurosciences, St. Joseph’s Healthcare Hamilton (Hamilton, Ontario)

 

Sidney Kennedy, MD, FRCPC

Professor of Psychiatry, University of Toronto (Toronto, Ontario); Arthur Sommer Rotenberg Chair in Suicide and Depression Studies, St. Michael’s Hospital (Toronto, ON); Scientist, Li Ka Shing Knowledge Institute, St. Michael’s Hospital (Toronto, Ontario); Scientist, Krembil Research Institute, University Health Network (Toronto, Ontario)

 

Raymond Lam, MD, FRCPC

Professor & Head, Mood and Anxiety Disorders Program, Department of Psychiatry, Faculty of Medicine, University of British Columbia (Vancouver, British Columbia)

 

Roumen Milev, MD, PHD, FRCPSYCH, FRCPC

Professor of Psychiatry and Psychology; Director, Centre for Neuroscience Studies, Queen’s University (Kingston, Ontario)

 

Sagar Parikh, MD

John F. Greden Professor of Depression and Clinical Neuroscience; Professor of Psychiatry; Professor of Health Management and Policy, School of Public Health; Associate Director, University of Michigan Comprehensive Depression, University of Michigan (Ann Arbor, Michigan)

 

Janice Pong, MSc

Communications and Research Manager, Centre for Depression and Suicide Studies, St. Michael's Hospital (Toronto, Ontario)

 

Susan Rotzinger, PhD

Assistant Professor, Department of Psychiatry, University of Toronto (Toronto, Ontario)

 

Anum Shivji Arwani, MSc

Outreach Coordinator, Centre for Depression and Suicide Studies, St. Michael's Hospital (Toronto, Ontario)

 

EVENT PARTNERS

 

Depression in 2020: Biomarkers, Technologies and Novel Therapies Conference is co-organised by the Canadian Network for Mood and Anxiety Treatments (CANMAT) and the Canadian Biomarker Integration Network for Depression (CAN-BIND). For more information about CAN-BIND, visit www.canbind.ca or follow them on Twitter and/or Facebook @CANBIND.



Liked this event? Spread the word :

Map Chelsea Hotel, Toronto, Canada
Loading venue map..
Event details from Report a problem

Are you going to this event?

Organizer

ASR Suicide and Depression Studies Program - St. Michael's Hospital
Advertisement